- AiCure is a leading AI and advanced data analytics company based in Houston, Texas, focused on transforming clinical trials and enhancing patient engagement through innovative technology solutions.
- In May 2025, AiCure appointed Sabina Chadha as CEO, with Ed Ikeguchi transitioning to Chief Medical Officer and Josh Wilson promoted to COO and President, reflecting a strategic leadership overhaul.
- AiCure has been involved in notable projects such as a PTSD study utilizing its precision medicine technology, showcasing its commitment to advancing healthcare through digital biomarkers.
- The ideal buyer for AiCure's solutions includes pharmaceutical companies and clinical research organizations looking to improve medication adherence and streamline clinical trial processes, making it a critical time for sales teams to engage with these stakeholders.
AiCure's workforce comprises nine departments, with Operations being the largest at seven employees, followed closely by Engineering with five. Information Technology supports the infrastructure with four team members. The balance across departments indicates a strong operational focus, while the presence of smaller teams in Finance, Executive, and Community and Social Services highlights a commitment to diverse functional areas.
The company operates across eight locations, with the largest concentration in New York, NY, housing six employees. Other notable locations include Mount Kisco, NY, and Ann Arbor, MI, each with one employee. The 'Other' category accounts for 16 employees, indicating a significant remote or distributed workforce, which may enhance operational flexibility and access to talent across various regions.
